Tingfei Tan

Co-delivery of paclitaxel (PTX) and docosahexaenoic acid (DHA) by targeting lipid nanoemulsions for cancer therapy

Jihui Tang, Ying Zhang, Y. Ye, 2021, Drug delivery.

Genetic Polymorphisms in CYP2C19 Cause Changes in Plasma Levels and Adverse Reactions to Anlotinib in Chinese Patients With Lung Cancer

Quan Xia, Ziwei Cheng, Jiemei Jiang, 2022, Frontiers in Pharmacology.

Relationship of cytochrome P450 gene polymorphisms with blood concentrations of hydroxychloroquine and its metabolites and adverse drug reactions

Quan Xia, Z. Shuai, Chun-Lan Yang, 2022, BMC medical genomics.

Paclitaxel-Loaded Macrophage Membrane Camouflaged Albumin Nanoparticles for Targeted Cancer Therapy

Quan Xia, Ya-ru Liu, Yong Jin, 2020, International journal of nanomedicine.

Germacrone Regulates HBXIP-Mediated Cell Cycle, Apoptosis and Promotes the Formation of Autophagosomes to Inhibit the Proliferation of Gastric Cancer Cells

Quan Xia, Tingting Liu, Tingfei Tan, 2020, Frontiers in Oncology.

Delivery of germacrone (GER) using macrophages-targeted polymeric nanoparticles and its application in rheumatoid arthritis

Qi Huang, Quan Xia, Bo Li, 2022, Drug delivery.

Relationship of cytochrome P450 gene polymorphisms with blood concentrations of hydroxychloroquine and its metabolites and adverse drug reactions

Quan Xia, Z. Shuai, Chun-Lan Yang, 2021, BMC Medical Genomics.